MLE and Bayesian Inference of Age-Dependent Sensitivity and Transition Probability in Periodic Screening
DOI10.1111/J.1541-0420.2005.00361.XzbMATH Open1087.62135OpenAlexW2025633407WikidataQ34977102 ScholiaQ34977102MaRDI QIDQ3379261FDOQ3379261
Authors: Dongfeng Wu, Gary L. Rosner, Lyle D. Broemeling 
Publication date: 6 April 2006
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: http://europepmc.org/articles/pmc1540406
Recommendations
- An age dependent stochastic model of periodic screening: Length bias at a prevalence screen
- Bayesian Inference for the Lead Time in Periodic Cancer Screening
- An age dependent stochastic model of periodic screening: Basic properties
- Bayesian and influence function‐based empirical likelihoods for inference of sensitivity to the early diseased stage in diagnostic tests
- Probability modeling and statistical inference in periodic cancer screening
- Bayesian assessment of times to diagnosis in breast cancer screening
- Empirical Bayes age-period-cohort analysis of retrospective incidence data
sensitivityMarkov chain Monte Carlosojourn timetransition probabilityearly detectionperiodic screening
Bayesian inference (62F15) Applications of statistics to biology and medical sciences; meta analysis (62P10) Numerical analysis or methods applied to Markov chains (65C40) Medical applications (general) (92C50)
Cites Work
- Markov chains for exploring posterior distributions. (With discussion)
- Simplified Models of Screening for Chronic Disease: Estimation Procedures from Mass Screening Programmes
- Testing the Independence of Two Diagnostic Tests
- Optimal scheduling of examinations for the early detection of disease
- Estimation of Sojourn Time in Chronic Disease Screening Without Data on Interval Cases
- Parametric estimation procedures for screening programmes: stable and nonstable disease models for multimodality case finding
- Evaluating the Age to Begin Periodic Breast Cancer Screening Using Data from a Few Regularly Scheduled Screenings
- Estimating Lead Time and Sensitivity in a Screening Program without Estimating the Incidence in the Screened Group
Cited In (10)
- Bayesian Semiparametric Estimation of Cancer-Specific Age-at-Onset Penetrance With Application to Li-Fraumeni Syndrome
- Quantification of length‐bias in screening trials with covariate‐dependent test sensitivity
- Gamma process-based models for disease progression
- Bayesian assessment of times to diagnosis in breast cancer screening
- Evaluating the Age to Begin Periodic Breast Cancer Screening Using Data from a Few Regularly Scheduled Screenings
- Tailored optimal posttreatment surveillance for cancer recurrence
- A Bayesian Random‐Effects Markov Model for Tumor Progression in Women with a Family History of Breast Cancer
- Screening for chronic diseases: optimizing lead time through balancing prescribed frequency and individual adherence
- Bayesian Inference for the Lead Time in Periodic Cancer Screening
- Markov Chain Monte Carlo Inference Applied to a Complex Model for the Longitudinal Analysis of Breast Patterns
This page was built for publication: MLE and Bayesian Inference of Age-Dependent Sensitivity and Transition Probability in Periodic Screening
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3379261)
